Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
Sales | 6,059,000 | 5,554,000 | 5,802,000 | 5,773,000 | 5,810,000 |
Cost of Goods | 1,024,000 | 944,000 | 1,059,000 | 990,000 | 1,024,000 |
Gross Profit | 5,035,000 | 4,610,000 | 4,743,000 | 4,783,000 | 4,786,000 |
Operating Expenses | 2,203,000 | 1,884,000 | 2,498,000 | 2,344,000 | 2,088,000 |
Operating Income | 2,832,000 | 2,726,000 | 2,245,000 | 2,439,000 | 2,698,000 |
Interest Expense | 347,000 | 338,000 | 332,000 | 325,000 | 321,000 |
Other Income | 162,000 | 231,000 | 301,000 | 267,000 | 165,000 |
Pre-tax Income | 2,647,000 | 2,619,000 | 2,214,000 | 2,381,000 | 2,542,000 |
Income Tax | 351,000 | 308,000 | 6,478,000 | 360,000 | 391,000 |
Net Income Continuous | 2,296,000 | 2,311,000 | -4,264,000 | 2,021,000 | 2,151,000 |
Net Income | $2,296,000 | $2,311,000 | $-4,264,000 | $2,021,000 | $2,151,000 |
EPS Basic Total Ops | 3.50 | 3.27 | -5.81 | 2.78 | 2.93 |
EPS Basic Continuous Ops | 3.50 | 3.27 | -5.81 | 2.78 | 2.93 |
EPS Diluted Total Ops | 3.48 | 3.25 | -5.77 | 2.76 | 2.91 |
EPS Diluted Continuous Ops | 3.48 | 3.25 | -5.77 | 2.76 | 2.91 |
EBITDA(a) | $3,316,000 | $3,197,000 | $2,694,000 | $2,903,000 | $3,216,000 |